fcx-007 vs zevaskyn

Both fcx-007 and zevaskyn are in development for recessive dystrophic epidermolysis bullosa (RDEB).

fcx-007zevaskyn
Developers11
Clinical trials00
FDA decisions00
Generic name—prademagene zamikeracel